Stockscreener 앱 받기
1.14
7.32%
-0.09
시장 영업 전:
1.14
전일 마감가:
$1.23
열려 있는:
$1.25
하루 거래량:
186.12K
Relative Volume:
2.17
시가총액:
$67.53M
수익:
-
순이익/손실:
$-25.65M
주가수익비율:
-2.3265
EPS:
-0.49
순현금흐름:
$-24.59M
1주 성능:
+0.00%
1개월 성능:
+9.62%
6개월 성능:
-19.15%
1년 성능:
-31.74%
1일 변동 폭
$1.11
$1.26
1주일 범위
$1.11
$1.28
52주 변동 폭
$0.9054
$2.09
Vivani Medical Inc Stock (VANI) Company Profile
명칭
Vivani Medical Inc
전화
818-833-5000
주소
1350 S. LOOP ROAD, ALAMEDA
VANI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.14 | 67.54M | 0 | -25.65M | -24.59M | -0.49 |
|
ONC
Beone Medicines Ltd Adr
|
251.72 | 25.78B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.48 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3401 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.81 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
487.86 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Vivani Medical Inc 주식(VANI)의 최신 뉴스
Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit - MSN
Companies To Watch: Vivani Medical - Life Science Leader
Vivani Medical spins off Cortigent as independent company By Investing.com - Investing.com South Africa
Vivani Medical Announces Spin-Off of Cortigent Subsidiary - TipRanks
Vivani Medical spins off Cortigent as independent company - Investing.com
Vivani (VANI) Plans to Spin Off Cortigent as an Independent Nasdaq Company | VANI Stock News - GuruFocus
Vivani Medical Announces Filing of Form 10 Registration - GlobeNewswire
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders - Yahoo Finance
Brokers Issue Forecasts for Vivani Medical Q1 Earnings - MarketBeat
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars - MSN
Vivani Medical's (VANI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Brokers Offer Predictions for Vivani Medical Q1 Earnings - Defense World
Vivani Medical (NASDAQ:VANI) Given “Buy” Rating at HC Wainwright - Defense World
Vivani Medical Reports Q1 2025 Results and Strategic Updates - TipRanks
Vivani Medical (VANI) Receives Continued 'Buy' Rating from HC Wainwright | VANI Stock News - GuruFocus
Vivani Medical: Q1 Earnings Snapshot - CT Insider
Vivani Medical Secures $3 Million in Share Purchase - TipRanks
Vivani Medical Q1 Basic EPS USD -0.11 - marketscreener.com
Vivani Medical Provides Business Update Including $3M - GlobeNewswire
Vivani Medical (VANI) to Release Quarterly Earnings on Monday - MarketBeat
Vivani Medical (VANI) to Release Earnings on Monday - Defense World
Vivani Medical to Present at the American Association of - GlobeNewswire
Vivani Medical to Present at the American Association of Pharmaceutical Scientists' 'Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - The Manila Times
Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - Yahoo Finance
Vivani Medical director Gregg Williams buys $1,124 in stock By Investing.com - Investing.com South Africa
Vivani Medical director Gregg Williams buys $1,124 in stock - Investing.com
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Vivani Medical Advances Drug Delivery Innovation with NanoPortal Technology - morgannewspaper.com
Head-To-Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical’s (VANI) “Buy” Rating Reiterated at HC Wainwright - Defense World
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - The Manila Times
Vivani Medical expands partnership with Okava for dog therapy By Investing.com - Investing.com South Africa
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - AOL.com
Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity - marketscreener.com
Vivani Medical expands partnership with Okava for dog therapy - Investing.com
Vivani Medical and Okava Expand Collaboration to Develop - GlobeNewswire
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Yahoo Finance
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 44,400 Shares of Stock - MarketBeat
Vivani medical director Gregg Williams invests $21,233 in shares By Investing.com - Investing.com Australia
Vivani medical director Gregg Williams buys $21,233 in stock By Investing.com - Investing.com Canada
Vivani Medical Inc (VANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.19%
자본화:
|
볼륨(24시간):